Understanding platelet reactivity, personalising DAPT

Session comprising selected EuroPCR 2016 abstract submissions

Chairperson: S. Garg

Presentations available when logged in:

  • Impact of greater than 12-month DAPT duration on mortality: drug-specific or a class-effect? - a meta-analysis
  • Six vs. 12 months of clopidogrel therapy after DES in patients with ACS: a subgroup analysis of the ISAR-SAFE study
  • Impact of chronic kidney disease on two-year clinical outcomes in patients treated with a six-month or 24-month DAPT duration: insights from the PR...
  • Prevalence and relation of CYP2C19 polymorphism with cardiovascular outcome in Iraqi Kurdish patients undergoing PCI
  • Impact of test conditions on the results of platelet function testing
  • Gender differences in platelet reactivity in patients receiving DAPT
  • Predicting the value of platelet reactivity on ischaemic events and bleeding in Eastern Asian PCI patients